Quagliariello, V., De Laurentiis, M., Cocco, S., Rea, G., Bonelli, A., Caronna, A., . . . Maurea, N. (2020). NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells. Int J Mol Sci.
Chicago-stil citatQuagliariello, Vincenzo, et al. "NLRP3 As Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells." Int J Mol Sci 2020.
MLA-referensQuagliariello, Vincenzo, et al. "NLRP3 As Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells." Int J Mol Sci 2020.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.